ALTERNATING USE OF DIFFERENT JAK1/JAK2 INHIBITORS, A POSSIBLE THERAPEUTIC STRATEGY USEFUL IN PRIMARY MYELOFIBROSIS: A CASE REPORT

被引：0
|
作者：
Gutierrez, Lopez de Ocariz X. [1 ]
Vera, Guerrero E. [1 ]
Carreno, Gomez-Tarragona G. [1 ]
Buendia, Urena B. [1 ]
De Nicolas, Sol R. [1 ]
Hidalgo, Soto M. [1 ]
Lopez, Munoz N. [1 ]
Zamanillo, Herreros, I [1 ]
Iniguez, Garcia R. [1 ]
Poza, Santaella M. [1 ]
Ayala, Diaz R. [1 ]
Martinez, Lopez J. [1 ]
机构：
[1] Hosp Univ 12 Octubre, Madrid, Spain
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB-059
引用
收藏
页码：395 / 395
页数：1
相关论文
共 50 条
  • [41] OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) IN PATIENTS WITH MYELOFIBROSIS (MF) EXPOSED TO JAK1/2 INHIBITORS
    Shanavas, M.
    Popat, U.
    Michaelis, L. C.
    Fauble, V.
    Mclornan, D.
    Klisovic, R.
    Mascarenhas, J.
    Tamari, R.
    Arcasoy, M.
    Davies, J.
    Gergis, U.
    Ukaegbu, O.
    Kamble, R.
    Storring, J.
    Majhail, N. S.
    Romee, R.
    Lew, J.
    Pagliuca, A.
    Vasu, S.
    Ernst, B.
    Atenafu, E.
    Hanif, A.
    Champlin, R.
    Hari, P.
    Gupta, V.
    HAEMATOLOGICA, 2015, 100 : 162 - 163
  • [42] AGGRESSIVE B-CELL LYMPHOMA IN PATIENT WITH MYELOFIBROSIS RECEIVING JAK2/1 INHIBITOR RUXOLITINIB: A CASE REPORT
    Rinaldi, E.
    Guaragna, G.
    Quintana, G.
    Spina, A.
    Merchionne, F.
    Pastore, D.
    HAEMATOLOGICA, 2019, 104 : 126 - 126
  • [43] A Case of Severe Hypocalcemia During JAK1/2 Inhibitor Therapy for Myelofibrosis in a Patient with Liver Cirrhosis
    Kurumazaki, Mayuna
    Ogawa, Noriko
    Kobayashi, Mariko
    Ikejiri, Fumiyoshi
    Kanasaki, Keizo
    INTERNAL MEDICINE, 2025,
  • [44] The Interaction between IPSS Score and JAK2 Mutation Identifies Patients at Different Vascular Risk in Primary Myelofibrosis
    Barbui, Tiziano
    Ghirardi, Arianna
    Carobbio, Alessandra
    Masciulli, Arianna
    Carioli, Greta
    Rambaldi, Alessandro
    Finazzi, Maria Chiara
    Bellini, Marta
    Rumi, Elisa
    Vanni, Daniele
    Borsani, Oscar
    Passamonti, Francesco
    Mora, Barbara
    Brociner, Marco
    Vannucchi, Alessandro
    Guglielmelli, Paola
    Paoli, Chiara
    Alvarez-Larran, Alberto
    Triguero, Ana
    Garrote, Marta
    Pettersson, Helna
    Andreasson, Bjorn
    BLOOD, 2021, 138
  • [45] Effect of pre-transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosis
    Cyriac, Sunu
    Prem, Shruti
    Salas, Maria Queralt
    Chen, Shiyi
    Al-Shaibani, Zeyad
    Lam, Wilson
    Law, Arjun
    Gupta, Vikas
    Michelis, Fotios V.
    Kim, Dennis
    Lipton, Jeffrey
    Kumar, Rajat
    Mattsson, Jonas
    Viswabandya, Auro
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (05) : 517 - 528
  • [46] SPENCD Presenting with Evans Phenotype and Clinical Response to JAK1/2 Inhibitors—a Report of 2 Cases
    Akshaya Chougule
    Prasad Taur
    Vijaya Gowri
    Mukesh M. Desai
    Journal of Clinical Immunology, 2023, 43 : 331 - 334
  • [47] The Small Molecule JAK1/JAK2 Inhibitor INCB16562 Shows Single Agent Activity and Strongly Synergizes with Bcl-2 Inhibitors in Lymphoma
    Derenzini, Enrico
    Lemoine, Manuela
    Brighenti, Elisa
    Davis, Richard Eric
    Zinzani, Pier Luigi
    Younes, Anas
    BLOOD, 2011, 118 (21) : 1175 - 1175
  • [48] Treatment of JAK2 V617F-positive primary myelofibrosis and advanced chronic myelogenous leukemia with ruxolitinib and flumatinib: a case report
    Zhu, Feng
    Wang, Hui
    Qiu, Lei
    ANNALS OF MEDICINE AND SURGERY, 2025, 87 (03): : 1750 - 1754
  • [49] Transcriptome profiling reveals target in primary myelofibrosis together with structural biology study on novel natural inhibitors regarding JAK2
    Li, Weihang
    Yuan, Bin
    Zhao, Yingjing
    Lu, Tianxing
    Zhang, Shilei
    Ding, Ziyi
    Wang, Dong
    Zhong, Sheng
    Gao, Guangxun
    Yan, Ming
    AGING-US, 2021, 13 (06): : 8248 - 8275
  • [50] Dose-Response Analyses Of Momelotinib (CYT387), a JAK1 and JAK2 Inhibitor, From a Phase I/II Study (CCL09101) In Treatment Of Myelofibrosis
    Xin, Yan
    Shao, Lixin
    Deng, Wei
    Niforos, Demi
    Kowalski, Mark
    Bavisotto, Linda M.
    Kawashima, Jun
    Jun, Susie
    Collins, Helen
    Ramanathan, Srinivasan
    BLOOD, 2013, 122 (21)
12345